This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Griffith University. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Queensland, AU (2019)
- Holmview, AU (2023)
Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Michael Raymond Batzloff
Introduction
Michael Raymond Batzloff is a notable inventor based in Holmview, Australia. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of four patents to his name, Batzloff's work focuses on enhancing immune responses against group A streptococcal bacteria.
Latest Patents
Among his latest patents is an immunogenic peptide designed to elicit a mucosal immune response to group A streptococcal bacteria in mammals, including humans. This modified p145 peptide boasts enhanced mucosal immunogenicity, making it particularly effective when administered intramuscularly. Additionally, the patent suggests that co-administration of an S2 peptide or variant may further enhance the immune response.
Career Highlights
Batzloff is affiliated with Griffith University, where he continues to advance his research and innovation in immunology. His work has garnered attention for its potential applications in improving health outcomes related to bacterial infections.
Collaborations
Some of his notable coworkers include Michael Francis Good and Manisha Pandey, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Michael Raymond Batzloff's innovative work in immunology exemplifies the impact of research on public health. His patents reflect a commitment to advancing medical science and improving immune responses against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile